Recruiting Prostate Cancer Studies in Midlothian
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
This study is being done to answer the following question: Is the strategy to give higher doses of radiotherapy treatment over a shorter period of time using special equipment and fewer treatments (al...
TERPS Trial for De Novo Oligometastic Prostate Cancer
This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis....
About Prostate Cancer Clinical Trials in Midlothian
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Midlothian, VA. These studies are seeking a combined 832 participants. Research is being sponsored by Canadian Cancer Trials Group, University of Maryland, Baltimore. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Midlothian — FAQ
Are there prostate cancer clinical trials in Midlothian?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Midlothian, VA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Midlothian?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Midlothian research site will contact you about next steps.
Are clinical trials in Midlothian free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Midlothian studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Midlothian are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov